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An  aliogeneic  mixed  leukocyte reaction  (MLR)  1 offers an  ideal  system  to 
analyze interactions among various phenotypically and functionally distinct sub- 
sets of T  lymphocytes. Allospecific helper,  inducer, suppressor,  and cytotoxic 
functions are all activated in this reaction (1-1 1). Although alloantigen-specific 
suppressor T  cells are generated in MLR, neither their mechanism of action nor 
the cellular and molecular signals that lead to the activation of suppressor T  cells 
as opposed to cytotoxic T  cells are understood. 
In earlier studies we observed that subsequent to mitogen-induced activation, 
T  cells of helper/inducer lineage (Leu-3+,OKT4+) stimulated fresh T  cells of 
suppressor/cytotoxic lineage (Leu-2+,OKT8+) to proliferate. Moreover, follow- 
ing activation by autologous mitogen-activated Leu-3+ cells,  these Leu-2+ cells 
were capable of inhibiting the response of fresh T  cells to a  variety of stimuli 
(12,  13).  The present  study was  undertaken to analyze the  functional conse- 
quences of exposing fresh T  cells to alloactivated T  cells.  The results indicate 
that Leu-2+ T  cells respond to ailoactivated autologous Leu-3+ T  cells and that 
subsequent to activation these cells specifically suppress the proliferation of fresh 
autologous Leu-3+ T  cells to the original allogeneic stimulator cells but not to 
the third party allogeneic stimulators. 
Materials and Methods 
Separation of E-Rosette-forming and Nonrosette-forming Cells  from Pe~pheral Blood Lympho- 
cvtes.  Peripheral  blood mononuclear cells from healthy human donors were obtained by 
l~icoll-Hypaque gradient centrifugation (14). T cells and non-T cells were separated by a 
single step rosetting method (15) using 2-aminoethylisothiouronium  bromide hydrobro- 
mide (Sigma Chemical Co., St. Louis, MO)-treated sheep erythrocytes (AET.SRBC) and 
a  second  Ficoil-Hypaque  gradient  to  separate  the  rosette-forming  T  cells from  the 
nonrosetting (non-T) cells. The rosetted T cells were freed from SRBC by hypotonic lysis 
of the latter and an aliquot was set aside for assessment of purity as has been previously 
described  (16). The T  cell fraction contained >95%  E-rosette-forming cells and <5% 
alpha naphthyl acetate esterase (ANAE)-positive phagocytic cells or surface Ig+ B cells. 
The non-T cell fraction included  40-50%  SIg+ B cells, 25-40%  ANAE+ phagocytic 
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plastic-adherent monocytes and  5-10%  nonadherent  nonphagocytic SIg- non-T-non-B 
(null) cells. 
Monoclonal Antibodies.  The monoclonal antibodies used in  this study were produced 
by the  method  of somatic cell  hybridization  (17).  Those antibodies  defining  mutually 
exclusive  and  functionally  distinct  T  cell  subsets,  anti-Leu-2a  and  anti-Leu-3a,  were 
generously provided by Dr. R. L. Evans, Memorial SIoan-Kettering Cancer Center, New 
York and have been described previously (18-20).  Antibody 9.3 reacts with 60-80% of 
peripheral T  cells (21) and was a generous gift from Dr. J. A. Hansen, Fred Hutchinson 
Cancer  Research  Center,  Seattle.  Fluorescein-conjugated  anti-human  HLA-DR frame- 
work antibody was obtained from Becton Dickinson Corp. (Mountain View, CA). 
Isolation of T Cell Subpopulations.  T  cell subsets were obtained by a panning technique 
(22) that permitted the fractionation of fresh or cultured T  cells into Leu-2-1-/Leu-2- or 
Leu-3+/Leu-3-  subpopulations (19,  20).  The purity of both positively and  negatively 
selected subsets was determined by indirect immunofluorescence analysis on an Ortho 
Cytofluorograph System 5OH  (Ortho  Diagnostics,  Westwood,  MA).  If anti-Leu-3  was 
used as the first stage incubating antibody, then <2% of the unbound cells were Leu-3+. 
Similar subset purity was achieved when anti-Leu-2 was used as the first stage incubating 
antibody. Earlier studies from this laboratory (19, 20) have shown that Leu-2+ cells and 
Leu-3+ cells isolated by positive selection (that is, having bound antibody) do not differ 
in  responsiveness  to  a  variety of stimuli  from  the  same  subset  enriched  by  negative 
selection  (lacking bound  antibody).  To assure purity, positively selected T  cell  subsets 
were used whenever possible in the experiments reported here. In some experiments Leu- 
3- cells (Leu-2+) were further separated into 9.3+ and 9.3- subsets by panning with the 
9.3  antibody.  Cytofluorographic  analysis  of the  9.3-  subpopulation  of  Leu-2+  cells 
showed that <4% of the unbound cells were 9.3+.  Isolated subsets were suspended to 1 
×  106 cells/ml in RPMI 1640 supplemented with 25 mM Hepes, 2 mM L-glutamine, 100 
tzg/ml streptomycin, 100 U/ml penicillin, 5 x  10 -~ M 2-mercaptoethanol and 20% heat- 
inactivated pooled human serum, hereafter referred to as complete medium. During the 
entire process of separation of T  cells and their subpopulations, pooled heat-inactivated 
normal human serum was used as a source of serum. 
Cell Cultures.  For activation of T  cell subsets in allogeneic MLR, 5 x  104 Leu-2+ or 
Leu-3+  cells  were  cultured  with  an  equal  number  of irradiated  (3,000  rads  from  a 
137cesium unit,  Shepherd JL and Assoc., Glendale, CA) allogeneic non-T cells in 0.2 ml 
of complete medium in 96-well round-bottom microtiter plates (Linbro, Flow Laborato- 
ries,  McLean, VA).  Cultures were maintained for 7 d  at 37°C in humidified  10% CO2 
atmosphere. Thereafter, ceils from each well were pooled, washed, and enriched for T 
cells by E-rosette formation as described above. In primary cultures, 5  x  104 responder 
Leu-2+ or Leu-3+ T  cells were cultured with an equal number of irradiated (2,000 rads) 
alloactivated or nonactivated autologous Leu-2+ or Leu-3+ cells in round-bottom micro- 
titer plates as described above. T  cells obtained from the above cultures after 7 d, were 
treated with mitomycin C (MMC, Sigma Chemical Co., St.  Louis, MO; 50 tzg/ml at 37°C 
for 30 min) and washed extensively before their coculture with 5 x  104 fresh autologous 
Leu-3+  cells  and  5  x  104  irradiated  allogeneic  non-T  cells  in  order  to  assess  their 
regulatory influence on MLR. 
To measure T  cell proliferation  1 ~Ci/weli of [~H]thymidine (New England Nuclear, 
Boston, MA;  6.7  Ci/mM) was added to triplicate cultures  18  h  before harvesting cells 
with a Mash II apparatus (Microbiological Associates, Walkersviile, MD). The incorpora- 
tion of radiolabel in the cultures was measured by a Beckmann LS 7000 liquid scintillation 
spectrometer and the results are expressed as counts per minute (cpm) +  standard error 
of the mean (SEM). 
The percent suppression was calculated by the following equation: 
cpm in cultures with activated T  cells as re~julators~ 
% Suppression =  100  ×  1 -  cpm in cultures with control T  cells as regulators ]" 
Negative values of suppression represent enhancement. DAMLE AND ENGLEMAN  161 
Results 
Proliferative Response of T  Cell Subsets to Alloactivated  T Cells.  Leu-2+ or Leu- 
3+ T  cells were cultured with irradiated allogeneic non-T cells for 7 d. Experi- 
ments not shown indicated that following such cultures 60-80% of Leu-3+ cells, 
but only 5-20% of Leu-2+ cells expressed Ia antigens based on cytofluorographic 
analysis with a  monoclonal anti-human HLA-DR framework-specific antibody. 
Cells recovered from the above cultures were enriched for T  cells by E-rosetting, 
irradiated, and tested for their ability to stimulate proliferation of fresh autolo- 
gous Leu-2+ or Leu-3+ cells. As shown in Table I, fresh Leu-3+ cells responded 
vigorously to autoiogous non-T cells, but weakly to alloactivated Leu-3+ cells. 
In contrast, fresh Leu-2+ cells exhibited significant proliferation when cultured 
with alloactivated autologous Leu-3+ cells but lacked responsiveness to autolo- 
gous non-T cells as has been shown previously (19, 23). Neither T  cells cultured 
alone nor Leu-2+ cells cultured with allogeneic non-T cells induced proliferation 
of fresh autologous Leu-2+ or Leu-3+ cells. 
Regulatory  Influence  of  T  Cell  Subsets Activated  with  Alloantigen-primed  T 
Cells.  The overall experimental design for these experiments is shown in Fig. 
1.  T  cell subsets were stimulated with alloantigen-primed autologous T  cells, 
reisolated,  and  examined for  their  regulatory  influence on  the  proliferative 
response of fresh autoiogous Leu-3+ cells in  MLR.  Fig.  2  shows that  Leu-2+ 
cells subsequent to their activation with alloantigen-primed autologous Leu-3+ 
cells suppressed,  in a  dose-related manner, the proliferative response of fresh 
autologous Leu-3+ cells in MLR. In contrast, Leu-2+ cells isolated from cultures 
stimulated either with alloactivated Leu-2+ cells or with nonactivated Leu-2+ or 
Leu-3+ cells had no effect on the proliferation of autologous Leu-3+ cells in 
MLR.  Leu-3+ cells isolated from cultures stimulated with either alloactivated 
Leu-2+ cells or nonactivated Leu-3+ cells had no effect on the proliferation of 
autologous Leu-3+ cells. Moreover, Leu-3+ cells recovered from cultures stim- 
ulated with alloantigen-primed autologous Leu-3+ cells induced significant en- 
hancement of autologous Leu-3+ cell-proliferation in MLR. 
The suppressive influence of Leu-2+ cells activated with alloantigen-primed 
autologous Leu-3+ cells was specific for the original ailoantigenic stimulus,  in 
that these cells failed to suppress the proliferative response of fresh autologous 
TABLE  I 
Proliferative Response of T Cell Subsets to Various Autologous Stimulator Cells 
Experi-  Responder  T  cells 
ment 
SH-TdR incorporation  in cultures stimulated with* 
Nonactivated *  Alloactivated  Nonactivated  Alloactivated 
Non-T cells 
Leu-3+ cells  Leu-3+ cells  Leu-2+ cells  Leu-2+ cells 
l  Leu-2+ cells  785 ±  320  418 ±  46  7,405 ±  539  412 ±  61  506 ±  59 
Leu-3+ cells  17,806 ±  1,347  980 ±  102  1,329 ±  247  808 ±  105  616 +  105 
2  Leu-2+ cells  693 _  25  255 ±  25  6,869 ±  450  185 ±  6  216 ±  26 
Leu-3+ cells  12,886 ±  978  259 ±  18  359 ±  60  386 ±  85  446 ±  55 
3  Leu-2+ cells  971 ±  81  737 ±  85  3,290 ±  191  469 ±  45  650 ±  61 
Leu-3+ cells  7,791 ±  551  349 ±  51  268 ±  61  133 ±  6  293 ±  25 
4  Leu-2+ cells  317 ±  88  3,39 ±  37  5,382 ±  906  268 ±  75  403 ±  75 
Leu-3+ cells  27,833 ±  205  1,028 ±  272  1,036 ±  97  1,017 ±  18  624 ±  152 
* Responder/stimulator  cell ratio of 1:2. 
Cultured alone in complete medium for 7 d. 
!  Mean of triplicate cpm ±  SEM. Background uptake was always <200 cpm. 162  IMMUNOREGULATORY T  CELL CIRCUITS IN MAN 
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FIGURE  1.  Schematic representation  of the overall experimental design for studies  of the 
regulation of MLR. 
Leu-3+ cells to third  party allogeneic non-T  cells (Table  II).  By contrast,  the 
enhancing effect of cultured Leu-3+ cells extended to the Leu-3+ cell-response 
to  third  party  allogeneic  stimuli  as  well  as  the  original  aliogeneic  stimulus, 
although  in most experiments  the enhancement  was greater when the original 
stimulator cells were used (Table II). 
Subpopulations  of Leu-2+  Cells  Responding  to  Autologous  Alloactivated  Leu-3+ 
Cells.  Antibody 9.3 reacts with 60-80% of peripheral  T  cells which include all 
or nearly all of the Leu-3+ cells and also a  subpopulation of Leu-2+ cells (24). 
Thus, the Leu-2+ subset can be divided into 9.3+ and 9.3- subpopulations. The 
proliferative response of 9.3+ and 9.3- subpopulations of Leu-3- (Leu-2+) cells 
to autologous alloactivated  Leu-3+ cells was studied.  Table  III shows that  the 
cells included  in  the  Leu-2+,9.3-  subpopulation  proliferated  to  ailoactivated 
Leu-3+ cells, whereas Leu-2+,9.3+ cells did not. 
The  9.3+  and  9.3-  subpopulations  of  Leu-2+  cells  were  stimulated  with 
alloactivated  Leu-3+ cells, reisolated into  Leu-2+ cells and examined for their 
suppressive effect on fresh MLR. The data in Fig. 3 demonstrate that suppressor 
activity induced  by alloantigen-primed  Leu-3+ cells was observed in  the  Leu- 
2+,9.3-  subpopulation  whereas  the  Leu-2+,9.3+  cells  recovered  from  these 
cultures had no detectable effect on the MLR response of fresh autologous Leu- 
3+ cells. Thus, the Leu-2+,9.3- subpopulation includes precursors of suppressor 
T  cells which can be activated by alloantigen-primed  Leu-3+ cells. 
Kinetics  of the  Suppressive  Effect  of Activated  Leu-2+  Cells  on  MLR.  In  the 
experiments described above, the proliferative response of Leu-3+ cells in  the 172 
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FIGURE 2.  Regulatory influence of T  cell subpopulations after activation with alloantigen- 
primed  T  cell  subsets.  Leu-2+  or  Leu-3+  cells were  activated with alloactivated or  naive 
autologous T  cells, reisolated, treated with mitomycin and then cocuhured in varying numbers 
with 5  x  10  + fresh autologous  Leu-3+  cells and 5  x  104 irradiated allogeneic non-T cells. 
[~H]Thymidine uptake in these cultures was measured on day 7. 
final  indicator  MLR cultures  was measured  at the  usual  time point  (day  7) of 
peak response in MLR (25). To assess the possibility that activated Leu-2+ cells 
might alter the kinetics of this response, Leu-2+ cells isolated subsequent to their 
activation with alloantigen-primed  Leu-3+ cells were cultured with fresh autolo- 
gous Leu-3+ cells and  the original  aliogeneic stimulator non-T cells. Replicate 
cultures  were harvested  on  varying  days and  the  results are  shown  in  Fig.  4. 
Suppression of the MLR response of Leu-3+ cells by activated Leu-2+ cells was 
observed throughout the culture period without evidence of altered kinetics.  In 
contrast, the MLR response of Leu-3+ cells was not inhibited at any time point 
by Leu-2+ cells that had been exposed to nonactivated Leu-3+ cells. 
We considered the possibility that the suppression of MLR by activated Leu- 
2+ cells was due to lysis by these cells of the stimulator non-T  cells leading to 
apparent  suppression  of  the  MLR  response.  However,  in  standard  4-6  h 164  IMMUNOREGULATORY T  CELL CIRCUITS IN MAN 
TABLE  II 
Spec~city of Activated Regulator T Cell Subsets 
Experi- 
ment 
Stimulation of 
Regulator  regulator cells  Original allogeneic 
T  cells  with  non-T cells 
3H-TdR incorporation in cultures stimulated with* 
Third party allogeneic 
non-T cells 
Leu-3+  Nonactivated  *  42,480 +  1,122 § 
cells  Leu-3+ cells 
Leu-3+  Alloactivated  52,712 +  2,039 (25%]') ! 
cells  Leu-3+ cells 
Leu-2+  Nonactivated  45,627 +_ 5,395 
cells  Leu-3+ cells 
Leu-2+  Alloactivated  22,784 +  3,691  (50%~,) 
cells  Leu-3+ cells 
Leu-3+  Nonactivated  13,598 +  2,650 
cells  Leu-3+ cells 
Leu-3+  Alloactivated  19,295 +  2,244 (42%~') 
cells  Leu-3+ cells 
Leu-2+  Nonactivated  20,607 +  3,597 
cells  Leu-3+ cells 
Leu-2+  Alloactivated  11,389 +  2,257 (45%~) 
cells  Leu-3+ cells 
37,814 _  3,490 
46,192 _+ 2,289 (22%~') 
35,076 +  5,200 
3%000+ 4,240 (6%T) 
24,136 __. 3,634 
30,699 +  2,068 (27%~') 
22,429 +  2,672 
22,793 +  4,511  (2%1') 
* Responder/regulator/stimulator cell ratio of 1  : 1  : 1. 
* Cultured alone in complete medium for 7 d. 
Mean of triplicate cpm +  SEM. Background uptake was always <200 cpm. 
!  Figures in parentheses indicate enhancement (T) or suppression (~,). 
TABLE  III 
Proliferative Response of Subpopulations of Leu-2+ Cells to Autologous Stimulator Cells 
Experi-  Responder T  cells 
ment 
3H-TdR incorporation in cultures stimulated with* 
Nonactivated*  Alloactivated Leu-3+  Non-T cells  Leu-3+ cells  cells 
1  Leu-2+ cells  777 +  114 ~  181 +  34  14,001  +  824 
Leu-2+,9.3+ cells  326 +  19  684 +  72  918 _  173 
Leu-2+,9.3- cells  392 +  72  404 +  121  13,711  +  1,858 
2  Leu-2+ cells  596 +  71  373 _+_ 75  8,235 +  1,258 
Leu-2+,9.3+ cells  721  +  98  232 -+ 90  669 -  130 
Leu-2+,9.3- cells  684 +  92  231  +  91  14,469 -+ 1,947 
3  Leu-2+ cells  785 +  75  345 +  99  5,193 _  492 
Leu-2+,9.3+ cells  693 +  22  808 +_ 98  839 +  073 
Leu-2+,9.3-cells  317 +  67  469 +  98  9,651  +  1,244 
* Responder/stimulator ratio of 1:2. 
* Cultured alone in complete medium for 7 d. 
Mean of triplicate cpm + SEM. Background uptake was always <200 cpm. 
5~chromium  release  assays,  Leu-2+  cells stimulated  by  alloactivated  autologous 
Leu-3+  cells did not exhibit  any detectable  cytotoxic activity against  autologous 
or allogeneic  lymphoid  cells even at effector  to target  cell ratios as high as  100:1 
(data  not shown),  These  results thus argue  against  lysis of stimulator  non-T  cells 
as  a  mechanism  to  explain  the  observed  inhibition  of  the  MLR  response  and 
suggest  that  this  method  of Leu-2+  cell-activation results  in  the selective induc- 
tion  of suppressor  T  cells.  In  additional  studies,  fresh  Leu-3+  responder  cells DAMLE  AND  ENGLEMAN  165 
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were separated into 9.3+ and 9.3- subsets, stimulated with alloantigen-primed Leu-3+ cells 
and then tested for their ability to suppress a  fresh MLR between 5  x  10 4 fresh autologous 
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FIGURE 4.  Effect of activated Leu-2+ ceils on the kinetics of MLR response. 5 X  10 4 fresh 
Leu-3+ cells were mixed with 5  x  10  4 irradiated allogeneic non-T cells and were cultured 
alone (A) or with 5 X  10 4 Leu-2+ cells isolated from cultures with either alloantigen-primed 
Leu-3+ (O) or nonactivated Leu-3+ cells (0) or with medium alone (I-I). On days 3,  5,  7,  9, 
and  11  aliquots of cells were tested for [3H]thymidine uptake.  Data from two independent 
experiments are shown. 
were  stimulated  with  an  increasing  number  of allogeneic  non-T  cells  in  the 
presence  of a  fixed  number  of activated  Leu-2+  cells.  Fig.  5  shows that  the 
inhibition  by activated  Leu-2+  cells was observed at  all  the  concentrations  of 
stimulator non-T cells tested, suggesting that the suppressive effect of activated 
Leu-2+  cells may be directed  toward  the  responder  Leu-3+  cells rather  than 
stimulator non-T cells. 
Effect  of Interleukin-2  on  the Suppression  by Activated  Leu-2+  Cells.  Absorption 
and  depletion  of interleukin-2  (IL-2) by putative  suppressor  T  cells has  been 
proposed as a  mechanism  to explain  the  antigen-specific  suppressor effects of 
mitogen-activated T  cells (26). To evaluate the effect of IL-2 on the suppressor 166  IMMUNOREGULATORY T  CELL CIRCUITS IN MAN 
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FIGURE 6.  Effect of interleukin-2 (IL-2) treatment of activated Leu-2+  suppressor cells of 
MLR. Leu-2+ cells isolated from cultures with alloantigen-primed Leu-3+ cells or nonactivated 
Leu-3+ cells, were incubated for 60 rain at 37°C with culture supernatant containing IL-2 
activity (10 U/ml), washed and then added to MLR between 5 ×  104 fresh Leu-3+ cells and 
5  x  104  irradiated  allogeneic  non-T  cells.  [SH]-Thymidine  uptake  in  these  cultures  was 
measured on day 7. 
cells under study, Leu-2+ cells derived from cultures stimulated with alloantigen- 
primed  Leu-3+ cells, were incubated at 37°C for 60 min with  IL-2 containing 
(10  U/ml)  culture  supernatant  of  MLA  144,  a  gibbon  leukemia  line  that 
constitutively produces  IL-2  (27).  These cells were then  washed and  added  to 
the final indicator MLR cultures.  Fig. 6 shows that the suppressor effect of the 
activated  Leu-2+  cells  was  not  reduced  by  incubation  of  these  cells  in  the 
conditioned medium containing IL-2. 
Effect of  Activated Leu-2+ Cells Added After Initiation of  MLR.  In the experiments 
described above, activated Leu-2+ cells were added at the initiation of indicator 167 
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FIGURE  7.  Effect of delayed addition of activated Leu-2+ cells to MLR. 5 X 10  4 Leu-2+ cells 
isolated from cultures with alloantigen-primed Leu-3+  cells, were added at  different times 
after  initiation  of MLR  consisting of 5  x  10  4 fresh  Leu-3+  cells and  5  X  10  4 irradiated 
allogeneic non-T cells. [SH]Thymidine uptake in these cultures was measured on day 7. 
MLR cultures.  It was of interest to determine whether suppressor T  cells exert 
inhibitory effects at an early or late stage of T  cell activation.  To address this 
question, Leu-2+ cells activated with alloantigen-primed Leu-3+ cells were added 
at  different  time  points  to  replicate  MLR  and  their  suppressive  effects were 
measured on day 7. It is apparent from Fig. 7 that activated Leu-2+ cells added 
as late as 24 h  after initiation  of the  MLR could still  suppress the response of 
fresh  Leu-3+  cells.  However, if the  addition  of activated  Leu-2+  cells to  the 
MLR was further delayed, no inhibition was observed, suggesting that suppressor 
Leu-2+ cells affect an early stage in the activation of Leu-3+ cells in MLR. Once 
activated, these Leu-3+ cells cannot be suppressed by activated Leu-2+ cells in 
this system. 
Discussion 
This study was an attempt to elucidate the mechanism whereby suppressor T 
cells are  induced  in  MLR.  Leu-3+  cells activated  with  allogeneic  non-T  cells 
acquired the ability to stimulate proliferation  of fresh autologous Leu-2+ cells. 
Following their  proliferation  and  presumed  differentiation,  Leu-2+  cells sup- 
pressed  the  response  of fresh  autologous  Leu-3+  cells  in  a  dose-dependent 
manner to the original, but not to third party, ailogeneic non-T cells in the MLR 
(Fig. 2 and Table II). Thus the data reported here extend previous findings in 
an antigen-nonspecific  system (12,  13) to an antigen-specific one. Although  the 
antigenic stimulus for the induction of suppression was not defined here, previous 
studies have suggested that products of HLA-DR or linked loci are major stimuli 
(10,  11). 
The mechanism whereby activated Leu-2+ cells suppress proliferation in MLR 
was not completely elucidated, although several possibilities were examined. Leu- 168  IMMUNOREGULATORY  T CELL CIRCUITS IN MAN 
2+  suppressor cells had not been directly exposed to either class  I  or class  II 
alloantigen-bearing non-T cells that classically serve as stimulators and targets 
for cytotoxic T  cells. Furthermore, the Leu-2+ cells that responded to alloanti- 
gen-primed autologous Leu-3+ cells lacked detectable cytolytic activity for au- 
tologous or allogeneic targets. Therefore, cytolysis of stimulator allogeneic non- 
T  cells by activated Leu-2+ cells does not appear  to be responsible for their 
suppressive effect. Although Leu-2+ cell-mediated lysis of alloantigen-responsive 
Leu-3+  cells in  the final indicator  MLR cannot be completely ruled out,  the 
observation that delayed addition of activated Leu-2+ cells to MLR cultures did 
not result in suppression (Fig. 7) argues against this possibility. Selective absorp- 
tion of IL-2 by suppressor T  cells (26) also seems unlikely as the treatment of 
activated Leu-2+ cells with IL-2 containing medium had no effect on their ability 
to inhibit the MLR response of fresh autologous Leu-3+ cells. Furthermore, the 
fact that the suppression exerted by these cells was antigen-specific argues against 
growth factor depletion as an explanation for the suppression of the MLR. 
In the present study, suppressor T  cell activity was confined to the Leu-2+ 
subset. Using different assay systems, investigators have described the develop- 
ment of suppressor activity in the Leu-3+ (OKT4+) subset (28, 29).  However, 
in the current study Leu-3+ cells cultured with alloantigen-primed Leu-3+ cells 
not only failed to suppress,  but consistently augmented the MLR  response of 
fresh Leu-3+ cells. As shown in Table II, this enhancement was greatest when 
the  original  allogeneic cells  were  used  as  stimulators  in  the  indicator  MLR, 
although the response to third party allogeneic stimuli was augmented to a lesser 
degree. One possible explanation for this partial  specificity may be that some 
irradiated ailoantigen-primed Leu-3+ cells remained viable in the culture and 
upon  reexposure to  the  original  stimulator  cells  released antigen-nonspecific 
growth-promoting factors. The alternative possibility that antigen-specific as well 
as  nonspecific helper  factors are released by  these  cells cannot be  excluded. 
Based  on  the observation  that  alloactivated  Leu-3+  cells enhanced the  fresh 
MLR, no further studies of this subset were undertaken. 
Although  the activation  of suppressor  T  cells appears  to  be  dependent on 
functionally intact inducer T  cells or their soluble products (30,  32),  it is not 
known whether the signals that activate cytotoxic T  cells also activate suppressor 
T  cells. Activation of cytotoxic T  cells in MLR is thought to be dependent on 
two types of inductive signals: an initial signal represented by class I alloantigens 
and a second signal delivered by alioactivated T  cells of helper/inducer lineage 
(6, 33-36). The data presented here indicate that structures either displayed on 
the surface of alioactivated Leu-3+ cells or secreted by them induce precursors 
of Leu-2+  suppressor  T  cells to  become suppressor-effectors in  the apparent 
absence of allogeneic stimulator cells. In this regard, a number of studies have 
shown  that  upon  activation  in  MLR  some T  cells synthesize and  express  Ia 
antigens of responder type (11, 37-41). In the present study a significant fraction 
of Leu-3+  but not  Leu-2+  cells recovered from MLR  were Ia+,  presumably 
reflecting the differential ability of cells within the two major sublineages of T 
cells to recognize and respond to class II MHC determinants (19).  Although Ia 
antigens on alloantigen-primed Leu-3+ cells might play a role in the activation 
of Leu-2+  suppressor  T  cells,  it  is  difficult  to  envisage  how  recognition  of DAMLE  AND  ENGLEMAN  169 
autologous Ia determinants could lead to alloantigen-specific suppression.  On 
the  other  hand,  the  induction  of Leu-2+  suppressor  cells  could  be  due  to 
recognition by these cells of allogeneic Ia antigens adsorbed onto the surface of 
alloactivated Leu-3+ cells (40) in a manner that leads to the selective activation 
of suppressor  but  not  cytotoxic or  helper/inducer cells.  Finally,  it  has  been 
reported that alloactivated T  cells express clonally specific (idiotypic) determi- 
nants that trigger a  specific proliferative response of fresh autologous T  cells 
(42, 43). An approach in which primed Leu-2+,9.3- suppressor cells are tested 
for their secondary proliferative response to either autologous alloactivated Leu- 
3+ cells or allogeneic non-T cells might help to distinguish between these two 
possibilities. 
Recent studies indicate that precursors of Leu-2+ alloantigen-specific cytotoxic 
T cells are included in the Leu-2+,9.3+ subset but not in the Leu-2+,9.3- subset 
of T  cells, whereas in a variety of systems all or nearly all Leu-2+ suppressor T 
cells are derived from the Leu-2+,9.3- subset (Damle, N., N. Mohagheghpour, 
J.  A.  Hansen, and E.  G.  Engleman, manuscript submitted for publication).  As 
shown  here,  Leu-2+  cells  that  proliferate  in  response  to  alloantigen-primed 
autoiogous Leu-3+ cells are included in the 9.3- but not in the 9.3+ subpopu- 
lation of Leu-2+ cells. In addition, the suppressor function activated by alioan- 
tigen-primed autologous Leu-3+ cells appears to be confined to the Leu-2+,9.3- 
subpopulation of Leu-2+ cells. These observations further support our conten- 
tion  that  precursors of suppressor  but  not cytotoxic T  cells are activated by 
alloantigen-primed autologous Leu-3+ cells. This type of T-T interaction appears 
to  be an  important  mechanism whereby suppressor  T  cells are preferentially 
activated by inducer T  cells. 
T cell circuits that regulate the immune response to antigens have been studied 
extensively in murine models and like the human system under study here, such 
circuits appear to be dependent on helper/inducer T  cells for their initiation 
(44).  For example, antigen-stimulated Lyt-l+ T  cells, in addition to helping B 
cells to differentiate into antibody-secreting plasma cells, also induce nonstimu- 
lated Lyt-1 +,2/3+,Qa-1 +  T  cells to mediate specific suppressor effects (32, 45). 
In the human T cell circuit, described schematically in Fig. 8, the Leu-3+ helper/ 
inducer population plays a central role in the activation of two types of negative 
feedback regulator cells: Leu-2+,9.3- suppressor cells, which presumably inhibit 
at the level of Leu-3+ helper/inducer cells and Leu°2+ cytotoxic cells, which 
eliminate allogeneic stimulator cells. Although functionally distinct subsets have 
been described within the Leu-3+ lineage (46, 48), it is not known whether the 
suppressor-inducer T  cells differ from the cytotoxic-inducer T  cells. Additional 
T  cell subsets, not depicted in this figure but involved in the regulation of other 
model systems of immunity, may also play a role in the regulation of MLR. For 
example,  optimal  suppression  of immunoglobulin  synthesis  in  vitro  requires 
collaboration  of at  least  two distinct  subsets  of Leu-2+  cells (47,  48),  one of 
which,  upon activation,  amplifies the suppressor  effects of fresh  Leu-2+ cells 
(47). It is not known whether Leu-2+ cells activated with the approach described 
here can amplify the suppressor effect of fresh Leu-2+ cells, since fresh Leu-2+ 
cells were not added to indicator MLRs to assess their regulatory effect. 
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FIGURE 8.  Schematic representauon of the cellular interactions involved in the induction of 
regulatory and effector mechanisms in the MLR. 
every individual tested to date using the above described approach.  However, it 
remains to be seen whether T-T interactions of the type described here apply in 
other antigen-specific systems and  in particular  to the response to soluble anti- 
gens.  If so,  a  general  scheme  can  be suggested  for  the  induction  of antigen- 
specific  suppressor  T  cells.  Conceivably,  suppressor  T  cells  with  a  variety  of 
specificities can be generated with this approach and used in the analysis of the 
molecular events that mediate feedback regulation of immunity. 
Summary 
Although  alloantigen-specific  suppressor  T  cells are generated  in  MLR,  the 
cellular signals that lead to activation of suppressor T cells as opposed to cytotoxic 
T  cells are unknown.  The current  study was undertaken  to characterize  inter- 
actions among T  cell subsets involved in the generation of suppressor T  cells in 
MLR.  Human  peripheral  blood  Leu-2+  (suppressor/cytotoxic)  and  Leu-3+ 
(helper/inducer)  T  cell subsets were activated with allogeneic non-T cells and 
then examined for their inductive effects on fresh autologous T  cells. Fresh Leu- 
2+ cells proliferated in response to alloantigen-primed  Leu-3+ cells and subse- 
quently suppressed the response of fresh autologous Leu-3+ cells to the original, 
but not third  party,  allogeneic stimulator  non-T cells.  Moreover, only Leu-2+ 
cells that  lacked the 9.3 marker,  an antigen  present on the majority of T  cells 
including  precursors  of cytotoxic T  cells,  differentiated  into  suppressor  cells. 
The alloantigen-specific suppressive effect of Leu-2+,9.3- cells was not mediated 
by cytolysis of allogeneic stimulator qells,  nor could it be explained by alteration 
of MLR kinetics.  Suppression  was observed only when  activated  Leu-2+  cells 
were added to fresh MLRs within 24 h of initiation  of cultures, suggesting that 
these cells block an early phase of the activation of Leu-3+ cells in MLR. These 
results indicate that alloantigen-primed  inducer T  cells can activate alloantigen- 
specific suppressor T  cells in the absence of allogeneic stimulator cells. 
Note added in proof."  Since submission of this manuscript, we have become aware 
of a report demonstrating the activation of influenza virus-specific suppressor T DAMLE AND  ENGLEMAN  171 
cells  by a  helper  T  cell  clone  (Lamb, J.  and  M.  Feldmann.  1982.  A  human 
suppressor  T  cell  clone  which  recognizes  an  autologous  helper  T  cell  clone. 
Nature  (Lond.).  300:456).  In  addition  we  have  succeeded  recently in  inducing 
specific suppressor T  cells with tuberculin PPD-primed inducer T  ceils. 
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Kamman for preparation of the manuscript. 
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